Provigil is a medication whose active ingredient modafinil promotes wakefulness by altering brain chemicals involved in sleep regulation. It is prescribed to treat excessive daytime sleepiness associated with narcolepsy shift work disorder and obstructive sleep apnea. The drug works by inhibiting the reuptake of dopamine and increasing its extracellular concentration which enhances alertness. Modafinil also influences histamine norepinephrine and serotonin pathways that contribute to arousal and cognitive function. Through these actions the medication improves sustained attention and reduces the tendency to fall asleep during the day. The overall effect is a targeted pharmacologic modulation of cortical networks that restores normal wakefulness patterns.

Provigil is the brand name for modafinil a medication that promotes wakefulness and is used to treat excessive sleepiness associated with narcolepsy shift work sleep disorder and obstructive sleep apnea. Its primary therapeutic role is to enhance alertness and reduce fatigue in patients who require sustained cognitive performance. The drug works by modulating neurotransmitter systems particularly by inhibiting the reuptake of dopamine and norepinephrine and by influencing histamine and orexin pathways to maintain cortical arousal. These actions increase extracellular dopamine and norepinephrine levels which contribute to improved wakefulness and reduced perception of fatigue. The mechanism also involves activation of hypocretin neurons that further support sustained alertness across the central nervous system. Overall Provigil pharmacology reflects a targeted enhancement of arousal circuits without producing classical stimulant effects.

Common side effects of Provigil include headache and nausea. Some users report decreased appetite and nervousness. Insomnia is reported by a portion of patients. Mild diarrhea and stomach discomfort may also occur. Less frequent reactions can involve anxiety and tremor. Skin rash and itching are occasionally observed. These reactions are generally mild and transient.

Provigil is known to cause occasional insomnia among users. Some individuals experience headaches during initial treatment periods. Appetite loss can lead to reduced food intake in a minority of cases. Nausea and mild stomach discomfort are reported symptoms. Anxiety or nervousness may appear as an early side effect. Skin rash or itching occurs infrequently but is documented. Dizziness or light-headedness can be observed in certain patients. Unusual taste sensations have been noted in isolated reports.